Table 2.
Multivariable logistic regression evaluating the association of MetS components and neuropathy
| Variable | Primary outcome | Secondary outcomes | |
|---|---|---|---|
| MNSI Examination OR (95% CI) | MNSI Questionnaire OR (95% CI) | Monofilament OR (95% CI) | |
| Demographics | |||
| Age | 1.10 (1.09, 1.12)a | 1.07 (1.05, 1.10)a | 1.10 (1.08, 1.12)a |
| Male (reference female) | 1.68 (1.14, 2.47)a | 2.03 (1.05, 3.91)a | 1.56 (1.05, 2.31)a |
| Height unit = 5 cm | 1.20 (1.05, 1.37)a | 0.89 (0.71, 1.10) | 1.14 (1.00, 1.15) |
| MetS components | |||
| Diabetes | 2.60 (1.77, 3.80)a | 3.85 (2.09, 7.09)a | 1.51 (1.01, 2.25)a |
| Prediabetes (reference normal) | 1.21 (0.84, 1.75) | 1.11 (0.60, 2.06) | 1.41 (1.00, 1.99) |
| Weight unit = 5 kg | 1.09 (1.02, 1.18)a | 1.00 (0.98, 1.03) | 1.00 (0.98, 1.01) |
| SBP unit = 10 mmHg | 1.04 (0.96, 1.11) | 0.93 (0.82, 1.05) | 1.07 (0.99, 1.15) |
| Triglycerides unit = 50 mg/dL | 1.01 (0.96, 1.06) | 0.90 (0.79, 1.02) | 0.94 (0.87, 1.01) |
| HDL unit = 10 mg/dL | 0.99 (0.87, 1.12) | 0.87 (0.69, 1.08) | 1.03 (0.91, 1.16) |
MetS, metabolic syndrome; MNSI, Michigan Neuropathy Screening Instrument; OR, odds ratio; SBP, systolic blood pressure; HDL, high‐density lipoprotein cholesterol.
a
P < 0.05.